Mangoceuticals, Inc.
MGRX
$2.49
-$0.08-3.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.54% | 16.39% | -0.99% | 7.80% | -42.71% |
| Total Depreciation and Amortization | 240,500.00% | -90.63% | -48.39% | -1.59% | 0.00% |
| Total Amortization of Deferred Charges | -292.18% | 8.49% | -- | -- | -- |
| Total Other Non-Cash Items | -17.06% | -30.31% | 93.09% | -43.36% | 316.94% |
| Change in Net Operating Assets | 370.50% | 93.09% | -131.62% | 1,379.48% | 156.27% |
| Cash from Operations | 3.11% | 26.08% | -59.14% | 41.62% | 0.76% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | 14.29% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 115.72% | -85.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -46.67% | -50.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 49.67% | -62.28% | 643.29% | -77.71% | -- |
| Foreign Exchange rate Adjustments | -1,540.00% | 54.55% | -1,000.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.32% | -187.66% | 165.62% | -45.41% | 70.91% |